Company intelligence
MLI Education
Leaders in Accredited Continuing Education for the Healthcare Team
About MLI Education
MLI is a provider of Interprofessional Continuing Education and has achieved Joint Accreditation with Commendation, allowing us to deliver accredited education designed to impact the practice behavior of the healthcare team, thus, improving patient outcomes. MLI provides credit for physicians, nurses, pharmacists, PAs, psychologists, social workers, dietitians, and optometrists. MLIʹs mission is to develop relevant, timely and targeted continuing education initiatives that promote problem‐solving and critical thinking.
Verified activity
Signals from MLI Education
4 published signals
Research & Knowledge
MLI Education published insights by Dr. Saad Usmani on combining CELMoDs with backbone agents to treat patients with myeloma.
Reported by MLI Education
Research & Knowledge
MLI Education released the successor-2 trial data showing half the progression of multiple myeloma using half the dose of a drug still used.
Reported by MLI Education
Legal & Regulatory
MLI Education reported that the FDA approved a new drug named iberdomide to treat multiple myeloma on August 13, 2026.
Reported by MLI Education
Presence & Recognition
MLI Education featured Dr. Saad Z. Usmani in a reelCE episode discussing how CELMoDs might change the treatment of multiple myeloma.
Reported by MLI Education